<html><head><link rel="stylesheet" type="text/css" href="css/style.css"></head><body><div id="main"><h1>Scignal</h1></div> <div class="container"><div class="row"><div class="search"><h2>All Results for : "Covid-19"</a></h2></div><table><tr><td class="head"><h3>BioRxiv</h3></td><td class="head"><h3>PubMed</h3></td></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Preliminary identification of potential vaccine targets for the COVID-19 coronavirus (SARS-CoV-2) based on SARS-CoV immunological studies</h4><p><a href="https://www.biorxiv.org/content/10.1101/2020.02.03.933226v4">Link</a></p><p><b>Date:</b> 2020-02-04</p><p><b>Authors:</b> Syed Faraz Ahmed ... Matthew R. McKay</p><p><b>Downloads:</b> 2857</p><p><b>Relevance Score:</b> 1.0</p></div><div class="everything-else-tail"><p><b>Abstract:</b> The beginning of 2020 has seen the emergence of COVID-19 outbreak caused by a novel coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).  There is an imminent need to better understand this new virus and to develop ways to control its spread.</p></div></td></div><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations and control measures, January 2020.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/32070465">Link</a></p><p><b>Date:</b> 02/19/2020</p><p><b>Authors:</b> Sibylle Bernard Stoecklin ...  None Investigation Team</p><p><b>Journal:</b> Euro Surveill.</p><p><b>IF (7 or above):</b> 7.37</p><p><b>Relevance Score:</b> 1.0</p></div><div class="everything-else-tail"><p><b>Abstract:</b> A novel coronavirus (severe acute respiratory syndrome coronavirus 2, SARS-CoV-2) causing a cluster of respiratory infections (coronavirus disease 2019, COVID-19) in Wuhan, China, was identified on 7 January 2020.  The epidemic quickly disseminated from Wuhan and as at 12 February 2020, 45,179 cases ....</p></div></td></div></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Machine learning using intrinsic genomic signatures for rapid classification of novel pathogens: COVID-19 case study</h4><p><a href="https://www.biorxiv.org/content/10.1101/2020.02.03.932350v3">Link</a></p><p><b>Date:</b> 2020-02-04</p><p><b>Authors:</b> Gurjit S. Randhawa ... Lila Kari</p><p><b>Downloads:</b> 2391</p><p><b>Relevance Score:</b> 1.0</p></div><div class="everything-else-tail"><p><b>Abstract:</b> As of February 20, 2020, the 2019 novel coronavirus (renamed to COVID-19) spread to 30 countries with 2130 deaths and more than 75500 confirmed cases.  COVID-19 is being compared to the infamous SARS coronavirus, which resulted, between November 2002 and July 2003, in 8098 confirmed cases worldwide with a 9.</p></div></td></div><td></td></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Structure of Mpro from COVID-19 virus and discovery of its inhibitors</h4><p><a href="https://www.biorxiv.org/content/10.1101/2020.02.26.964882v2">Link</a></p><p><b>Date:</b> 2020-02-27</p><p><b>Authors:</b> Zhenming Jin ... Haitao Yang</p><p><b>Downloads:</b> 2155</p><p><b>Relevance Score:</b> 1.0</p></div><div class="everything-else-tail"><p><b>Abstract:</b> A new coronavirus (CoV) identified as COVID-19 virus is the etiological agent responsible for the 2019-2020 viral pneumonia outbreak that commenced in Wuhan.  Currently there is no targeted therapeutics and effective treatment options remain very limited.</p></div></td></div><td></td></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Isolation and characterization of SARS-CoV-2 from the first US COVID-19 patient</h4><p><a href="https://www.biorxiv.org/content/10.1101/2020.03.02.972935v2">Link</a></p><p><b>Date:</b> 2020-03-03</p><p><b>Authors:</b> Jennifer Harcourt ... Natalie J. Thornburg</p><p><b>Downloads:</b> 1300</p><p><b>Relevance Score:</b> 1.0</p></div><div class="everything-else-tail"><p><b>Abstract:</b> The etiologic agent of the outbreak of pneumonia in Wuhan China was identified as severe acute respiratory syndrome associated coronavirus 2 (SARS-CoV-2) in January, 2020.  The first US patient was diagnosed by the State of Washington and the US Centers for Disease Control and Prevention on January 20, 2020.</p></div></td></div><td></td></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Design of multi epitope-based peptide vaccine against E protein of human COVID-19: An immunoinformatics approach</h4><p><a href="https://www.biorxiv.org/content/10.1101/2020.02.04.934232v2">Link</a></p><p><b>Date:</b> 2020-02-11</p><p><b>Authors:</b> Miyssa I. Abdelmageed ... Abdelrafie M. Makhawi</p><p><b>Downloads:</b> 1075</p><p><b>Relevance Score:</b> 1.0</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Background New endemic disease has been spread across Wuhan City, China on December 2019.  Within few weeks, the World Health Organization (WHO) announced a novel coronavirus designated as coronavirus disease 2019 (COVID-19).</p></div></td></div><td></td></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: The Essential Facts of Wuhan Novel Coronavirus Outbreak in China and Epitope-based Vaccine Designing against COVID-19</h4><p><a href="https://www.biorxiv.org/content/10.1101/2020.02.05.935072v2">Link</a></p><p><b>Date:</b> 2020-02-11</p><p><b>Authors:</b> Bishajit Sarkar ... Yusha Araf</p><p><b>Downloads:</b> 994</p><p><b>Relevance Score:</b> 1.0</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Wuhan Novel Coronavirus disease (COVID-19) outbreak has become a global outbreak which has raised the concern of scientific community to design and discover a definitive cure against this deadly virus which has caused deaths of numerous infected people upon infection and spreading.  To date, no antiviral therapy or vaccine is available which can effectively combat the infection caused by this virus.</p></div></td></div><td></td></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: CRISPR-based surveillance for COVID-19 using genomically-comprehensive machine learning design</h4><p><a href="https://www.biorxiv.org/content/10.1101/2020.02.26.967026v2">Link</a></p><p><b>Date:</b> 2020-03-02</p><p><b>Authors:</b> Hayden C. Metsky ... Cameron Myhrvold</p><p><b>Downloads:</b> 275</p><p><b>Relevance Score:</b> 1.0</p></div><div class="everything-else-tail"><p><b>Abstract:</b> The emergence and outbreak of SARS-CoV-2, the causative agent of COVID-19, has rapidly become a global concern and has highlighted the need for fast, sensitive, and specific tools to surveil circulating viruses.  Here we provide assay designs and experimental resources, for use with CRISPR-based nucleic acid detection, that could be valuable for ongoing surveillance.</p></div></td></div><td></td></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: The Pathogenicity of SARS-CoV-2 in hACE2 Transgenic Mice</h4><p><a href="https://www.biorxiv.org/content/10.1101/2020.02.07.939389v3">Link</a></p><p><b>Date:</b> 2020-02-11</p><p><b>Authors:</b> Linlin Bao ... Chuan Qin</p><p><b>Downloads:</b> 4528</p><p><b>Relevance Score:</b> 0.43</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Severe acute respiratory syndrome CoV-2 (SARS-CoV-2) caused the Corona Virus Disease 2019 (COVID-19) cases in China has become a public health emergency of international concern (PHEIC).  Based on angiotensin converting enzyme 2 (ACE2) as cell entry receptor of SARS-CoV, we used the hACE2 transgenic mice infected with SARS-CoV-2 to study the pathogenicity of the virus.</p></div></td></div><td></td></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Structural basis for the recognition of the 2019-nCoV by human ACE2</h4><p><a href="https://www.biorxiv.org/content/10.1101/2020.02.19.956946v1">Link</a></p><p><b>Date:</b> 2020-02-20</p><p><b>Authors:</b> Renhong Yan ... Qiang Zhou</p><p><b>Downloads:</b> 3494</p><p><b>Relevance Score:</b> 0.43</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Angiotensin-converting enzyme 2 (ACE2) has been suggested to be the cellular receptor for the new coronavirus (2019-nCoV) that is causing the coronavirus disease 2019 (COVID-19).  Like other coronaviruses such as the SARS-CoV, the 2019-nCoV uses the receptor binding domain (RBD) of the surface spike glycoprotein (S protein) to engage ACE2.</p></div></td></div><td></td></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Molecular Modeling Evaluation of the Binding Effect of Ritonavir, Lopinavir and Darunavir to Severe Acute Respiratory Syndrome Coronavirus 2 Proteases</h4><p><a href="https://www.biorxiv.org/content/10.1101/2020.01.31.929695v2">Link</a></p><p><b>Date:</b> 2020-02-03</p><p><b>Authors:</b> Shen Lin ... Xushun Guo</p><p><b>Downloads:</b> 2971</p><p><b>Relevance Score:</b> 0.43</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Three anti-HIV drugs, ritonavir, lopinavir and darunavir, might have therapeutic effect on coronavirus disease 2019 (COVID-19).  In this study, the structure models of two severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) proteases, coronavirus endopeptidase C30 (CEP\_C30) and papain like viral protease (PLVP), were built by homology modeling.</p></div></td></div><td></td></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Spike protein binding prediction with neutralizing antibodies of SARS-CoV-2</h4><p><a href="https://www.biorxiv.org/content/10.1101/2020.02.22.951178v1">Link</a></p><p><b>Date:</b> 2020-02-27</p><p><b>Authors:</b> Tamina Park ... Daeui Park</p><p><b>Downloads:</b> 2606</p><p><b>Relevance Score:</b> 0.43</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Coronavirus disease 2019 (COVID-19) is a new emerging human infectious disease caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2, also previously known as 2019-nCoV), originated in Wuhan seafood and animal market, China.  Since December 2019, more than 69,000 cases of COVID-19 have been confirmed in China and quickly spreads to other counties.</p></div></td></div><td></td></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Comparative analysis of primer-probe sets for the laboratory confirmation of SARS-CoV-2</h4><p><a href="https://www.biorxiv.org/content/10.1101/2020.02.25.964775v1">Link</a></p><p><b>Date:</b> 2020-02-27</p><p><b>Authors:</b> Yu Jin Jung ... Hong Gi Kim</p><p><b>Downloads:</b> 2296</p><p><b>Relevance Score:</b> 0.43</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Coronavirus disease 2019 (COVID-19) is newly emerging human infectious diseases, which is caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2, also previously known as 2019-nCoV).  Within two months of the outbreak, more than 80,000 cases of COVID-19 have been confirmed worldwide.</p></div></td></div><td></td></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Are pangolins the intermediate host of the 2019 novel coronavirus (2019-nCoV) ?</h4><p><a href="https://www.biorxiv.org/content/10.1101/2020.02.18.954628v1">Link</a></p><p><b>Date:</b> 2020-02-20</p><p><b>Authors:</b> Ping Liu ... Jinping Chen</p><p><b>Downloads:</b> 2103</p><p><b>Relevance Score:</b> 0.43</p></div><div class="everything-else-tail"><p><b>Abstract:</b> The outbreak of 2019-nCoV pneumonia (COVID-19) in the city of Wuhan, China has resulted in more than 60,000 laboratory confirmed cases, and recent studies showed that 2019-nCoV (SARS-CoV-2) could be of bat origin but involve other potential intermediate hosts.  In this study, we assembled the genomes of coronaviruses identified in sick pangolins.</p></div></td></div><td></td></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Potential T-cell and B-cell Epitopes of 2019-nCoV</h4><p><a href="https://www.biorxiv.org/content/10.1101/2020.02.19.955484v1">Link</a></p><p><b>Date:</b> 2020-02-21</p><p><b>Authors:</b> Ethan Fast ... Binbin Chen</p><p><b>Downloads:</b> 1432</p><p><b>Relevance Score:</b> 0.43</p></div><div class="everything-else-tail"><p><b>Abstract:</b> As of Feb 16th 2020, 2019-nCoV has infected more than 51,857 people across 26 countries and claimed 1666 lives.  2019-nCoV is a novel form of coronavirus that causes COVID-19 and has high similarity with SARS-CoV.</p></div></td></div><td></td></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Pangolin homology associated with 2019-nCoV</h4><p><a href="https://www.biorxiv.org/content/10.1101/2020.02.19.950253v1">Link</a></p><p><b>Date:</b> 2020-02-20</p><p><b>Authors:</b> Tao Zhang ... Zhigang Zhang</p><p><b>Downloads:</b> 1240</p><p><b>Relevance Score:</b> 0.43</p></div><div class="everything-else-tail"><p><b>Abstract:</b> To explore potential intermediate host of a novel coronavirus is vital to rapidly control continuous COVID-19 spread.  We found genomic and evolutionary evidences of the occurrence of 2019-nCoV-like coronavirus (named as Pangolin-CoV) from dead Malayan Pangolins.</p></div></td></div><td></td></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Multivariate Analyses of Codon Usage of SARS-CoV-2 and other betacoronaviruses</h4><p><a href="https://www.biorxiv.org/content/10.1101/2020.02.15.950568v3">Link</a></p><p><b>Date:</b> 2020-02-20</p><p><b>Authors:</b> Haogao Gu ... Leo L.M. Poon</p><p><b>Downloads:</b> 822</p><p><b>Relevance Score:</b> 0.43</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Coronavirus disease 2019 (COVID-19) is a global health concern as it continues to spread within China and beyond.  The causative agent of this disease, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), belongs to the genus Betacoronavirus which also includes severe acute respiratory syndrome related coronavirus (SARSr-CoV) and Middle East respiratory syndrome related coronavirus (MERSr-CoV).</p></div></td></div><td></td></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: No more business as usual: agile and effective responses to emerging pathogen threats require open data and open analytics</h4><p><a href="https://www.biorxiv.org/content/10.1101/2020.02.21.959973v2">Link</a></p><p><b>Date:</b> 2020-02-22</p><p><b>Authors:</b> Galaxy and HyPhy developments teams ... Sergei L. Kosakovsky Pond</p><p><b>Downloads:</b> 816</p><p><b>Relevance Score:</b> 0.43</p></div><div class="everything-else-tail"><p><b>Abstract:</b> The current state of much of the Wuhan pneumonia virus (COVID-19) research shows a regrettable lack of data sharing and considerable analytical obfuscation.  This impedes global research cooperation, which is essential for tackling public health emergencies, and requires unimpeded access to data, analysis tools, and computational infrastructure.</p></div></td></div><td></td></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Genome-wide data inferring the evolution and population demography of the novel pneumonia coronavirus (SARS-CoV-2)</h4><p><a href="https://www.biorxiv.org/content/10.1101/2020.03.04.976662v2">Link</a></p><p><b>Date:</b> 2020-03-07</p><p><b>Authors:</b> Bing Fang ... Yongzhong Jiang</p><p><b>Downloads:</b> 495</p><p><b>Relevance Score:</b> 0.43</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Since December 2019, coronavirus disease 2019 (COVID-19) emerged in Wuhan, Central China and rapidly spread throughout China.  Up to March 3, 2020, SARS-CoV-2 has infected more than 89,000 people in China and other 66 countries across six continents.</p></div></td></div><td></td></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: A simple magnetic nanoparticles-based viral RNA extraction method for efficient detection of SARS-CoV-2</h4><p><a href="https://www.biorxiv.org/content/10.1101/2020.02.22.961268v1">Link</a></p><p><b>Date:</b> 2020-02-27</p><p><b>Authors:</b> Zhen Zhao ... Xuefeng Yu</p><p><b>Downloads:</b> 377</p><p><b>Relevance Score:</b> 0.43</p></div><div class="everything-else-tail"><p><b>Abstract:</b> The ongoing outbreak of the novel coronavirus disease 2019 (COVID-19) originating from Wuhan, China, draws worldwide concerns due to its long incubation period and strong infectivity.  Although RT-PCR-based molecular diagnosis techniques are being widely applied for clinical diagnosis currently, timely and accurate diagnosis are still limited due to labour intensive and time-consuming operations of these techniques.</p></div></td></div><td></td></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites</h4><p><a href="https://www.biorxiv.org/content/10.1101/2020.03.06.977876v2">Link</a></p><p><b>Date:</b> 2020-03-07</p><p><b>Authors:</b> Sisi Kang ... Shoudeng Chen</p><p><b>Downloads:</b> 351</p><p><b>Relevance Score:</b> 0.43</p></div><div class="everything-else-tail"><p><b>Abstract:</b> The outbreak of coronavirus disease (COVID-19) in China caused by SARS-CoV-2 virus continually lead to worldwide human infections and deaths.  It is currently no specific viral protein targeted therapeutics yet.</p></div></td></div><td></td></tr></table></div><hr></div></body></html>